Hydroxyurea - Ch4n2o2 Compound | Effective Treatment For Chronic Myeloid Leukemia, Head And Neck Cancers, And Radiation Therapy Sensitization

These Hydroxyurea is mainly used for the treatment of chronic myeloid leukemia (CML), slow grow speed of the grain of red blood cells, genuine period and lost-voice disease, and it also has curative effect for head and neck primary squamous cell carcinoma, recurrent metastatic ovarian cancer, etc. And in radiation therapy and when used as radiotherapy sensitization agent, Hydroxyurea(COS) can increase the curative effect of head and neck cancer treatment

Name: Urea, N-hydroxy-
CAS No : 127-07-1
Formula: CH4N2O2
Synonyms: Urea,hydroxy- (6CI,8CI,9CI); Biosupressin; Carbamohydroxamic acid; Carbamohydroximicacid; Carbamoyl oxime; Droxia; HU; Hidrix; Hydrea; Hydreia; Hydroxycarbamide; Hydroxylamine, N-(aminocarbonyl)-; Hydura; Hydurea; Litaler; Litalir; N-Carbamoylhydroxylamine; NCI C04831; NSC 32065; Onco-Carbide; Oxyrea; Oxyurea; SK 22591; SQ 1089